Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.

Cell Metabolism
François R Jornayvaz, Gerald I Shulman

Abstract

Nonalcoholic fatty liver disease (NAFLD) is now the most frequent chronic liver disease in Western societies, affecting one in four adults in the USA, and is strongly associated with hepatic insulin resistance, a major risk factor in the pathogenesis of type 2 diabetes. Although the cellular mechanisms underlying this relationship are unknown, hepatic accumulation of diacylglycerol (DAG) in both animals and humans has been linked to hepatic insulin resistance. In this Perspective, we discuss the role of DAG activation of protein kinase Cε as the mechanism responsible for NAFLD-associated hepatic insulin resistance seen in obesity, type 2 diabetes, and lipodystrophy.

References

Jul 31, 1984·Biochemical and Biophysical Research Communications·R R Rando, N Young
Nov 30, 1999·JAMA : the Journal of the American Medical Association·H Cortez-PintoA M Diehl
Mar 18, 2000·The Journal of Biological Chemistry·J K KimG I Shulman
Jul 21, 2000·The Journal of Clinical Investigation·G I Shulman
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·J K KimG I Shulman
Feb 22, 2002·The New England Journal of Medicine·Elif Arioglu OralAbhimanyu Garg
Apr 19, 2002·The New England Journal of Medicine·Paul Angulo
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Yoshinori MiyazakiRalph A DeFronzo
Dec 24, 2002·The Biochemical Journal·Alexandra C Newton
May 17, 2003·Science·Kitt Falk PetersenGerald I Shulman
Jan 30, 2004·Annual Review of Medicine·Stanley T Crooke
Feb 13, 2004·The New England Journal of Medicine·Kitt Falk PetersenGerald I Shulman
May 29, 2004·The Journal of Biological Chemistry·Varman T SamuelGerald I Shulman
Aug 5, 2004·The Journal of Clinical Endocrinology and Metabolism·Amalia GastaldelliRalph A DeFronzo
Oct 16, 2004·Science·Umut OzcanGökhan S Hotamisligil
Jan 22, 2005·Science·Mitchell A Lazar
Oct 31, 2006·The Journal of Biological Chemistry·Daniel R DriesAlexandra C Newton
Nov 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Kitt Falk PetersenGerald I Shulman
Jun 16, 2007·The Journal of Clinical Investigation·Cheol Soo ChoiGerald I Shulman
Jul 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kitt Falk PetersenGerald I Shulman
Oct 10, 2007·Proceedings of the National Academy of Sciences of the United States of America·Cheol Soo ChoiGerald I Shulman
Oct 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Dongyan ZhangGerald I Shulman
Aug 13, 2008·Archives of Internal Medicine·Norbert StefanHans-Ulrich Häring
Jan 16, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·G S Hotamisligil
Jul 18, 2009·Science·Gary Taubes
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Elisa FabbriniSamuel Klein
Oct 6, 2009·Journal of Lipid Research·Gabriela Montero-MoranDawn L Brasaemle
Dec 31, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Elisa FabbriniSamuel Klein
Mar 26, 2010·The New England Journal of Medicine·Kitt Falk PetersenGerald I Shulman

❮ Previous
Next ❯

Citations

Jan 23, 1998·The International Journal of Biochemistry & Cell Biology·F Sakane, H Kanoh
May 15, 2013·The Proceedings of the Nutrition Society·Christopher D Byrne
Aug 23, 2012·Proceedings of the National Academy of Sciences of the United States of America·Whitney H BrownGerald I Shulman
Jan 11, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jennifer L CantleyGerald I Shulman
Jul 11, 2013·Proceedings of the National Academy of Sciences of the United States of America·Thomas GalboGerald I Shulman
Jul 9, 2013·The Journal of Endocrinology·Mohamed Asrih, François R Jornayvaz
Apr 3, 2014·Comprehensive Physiology·Liangyou Rui
Feb 18, 2014·Clinical Lipidology·Chongben ZhangRosalind A Coleman
Dec 7, 2013·Nature Medicine·Reuben J Shaw
Jun 14, 2013·Journal of Obesity·Scott M GrundyGloria Lena Vega
Feb 23, 2013·ISRN Endocrinology·Satoru MatsudaYasuko Kitagishi
Dec 8, 2014·Lipids in Health and Disease·Jinmei YaoJianping Wu
Sep 18, 2015·Critical Reviews in Clinical Laboratory Sciences·Kimber L Stanhope
Feb 21, 2014·Expert Review of Cardiovascular Therapy·John R Ussher
Oct 20, 2015·European Journal of Nutrition·Raffaella CrescenzoSusanna Iossa
Mar 27, 2015·Antioxidants & Redox Signaling·Vera B Schrauwen-HinderlingPatrick Schrauwen
Dec 10, 2015·European Journal of Endocrinology·Andressa CoopeLicio A Velloso
Sep 5, 2015·The Plant Journal : for Cell and Molecular Biology·Lin LiYan Wu
Oct 11, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Krzysztof KurekMałgorzata Zendzian-Piotrowska
Apr 17, 2016·European Journal of Pharmacology·Aoife A CookeHelen M Roche
Jul 24, 2015·The Journal of Endocrinology·João Paulo G CamporezFrançois R Jornayvaz
Nov 23, 2013·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Mohamed Asrih, François R Jornayvaz
Jul 8, 2014·Oxidative Medicine and Cellular Longevity·Antonio AyalaSandro Argüelles
Aug 12, 2015·Lipids in Health and Disease·Jon SkorveStefan E H Alexson
Jun 19, 2013·Molecular and Cellular Endocrinology·Chrysi Koliaki, Michael Roden
Feb 19, 2013·Cell·Andrew M F Johnson, Jerrold M Olefsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Nature Medicine
Derek M Erion, Gerald I Shulman
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Andreas L Birkenfeld, Gerald I Shulman
Proceedings of the National Academy of Sciences of the United States of America
Naoki KumashiroGerald I Shulman
© 2021 Meta ULC. All rights reserved